Product Information
IBUPROFEN 200 MG SOFTGEL is a generic product labeled by Cardinal Health, priced at $0.0762 per EA under NDC 70000057102. Its NADAC has been published 237 times since Mar 23, 2022.
FDA first approved this application on Mar 24, 2009.
Strength
200 mg/1
Manufacturer
Cardinal HealthNDC
70000057102
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA078682FDA Approved
3/24/2009
On Market Since
4/30/2021
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 200 MG SOFTGEL has been published 237 times since Mar 23, 2022, and over the history we have for it it has risen 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0762 per EA |
|---|---|
| All-time high | $0.0979 (Feb 15, 2023) |
| All-time low | $0.0720 (Mar 23, 2022) |
| 52-week high | $0.0816 |
| 52-week low | $0.0762 |
| Median price | $0.0799 |
| Average price | $0.0808 |
| Largest weekly change | -13.4% (Feb 22, 2023) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IBUPROFEN 200 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 200 MG SOFTGEL, manufactured by Cardinal Health, is $0.0762 per EA (NDC 70000057102), effective Sep 30, 2026.
How has the price of IBUPROFEN 200 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 200 MG SOFTGEL has risen 5.9%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 200 MG SOFTGEL?
Since Mar 23, 2022, the NADAC for IBUPROFEN 200 MG SOFTGEL has ranged from a low of $0.0720 (Mar 23, 2022) to a high of $0.0979 (Feb 15, 2023), with a median of $0.0799 per EA.
Are there cheaper alternatives to IBUPROFEN 200 MG SOFTGEL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as IBUPROFEN 200 MG SOFTGEL in a comparable dosage form, but none are currently priced below it.
Who manufactures IBUPROFEN 200 MG SOFTGEL?
IBUPROFEN 200 MG SOFTGEL (NDC 70000057102) is labeled by Cardinal Health, and CMS classifies it as a generic product.